KOESSLER, T., M. ALSINA, D. ARNOLD, I. BEN-AHARON, M. COLLIENNE, M. P. LUTZ, C. NEUZILLET, Radka OBERMANNOVÁ, M. PEETERS, F. SCLAFANI, E. SMYTH, J. W. VALLE, A. D. WAGNER, L. WYRWICZ, E. FONTANA a M. MOEHLER. ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective. ESMO OPEN. AMSTERDAM: ELSEVIER, 2022, roč. 7, č. 2, s. 1-8. ISSN 2059-7029. Dostupné z: https://dx.doi.org/10.1016/j.esmoop.2022.100392. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2250084, author = {Koessler, T. and Alsina, M. and Arnold, D. and BenandAharon, I. and Collienne, M. and Lutz, M. P. and Neuzillet, C. and Obermannová, Radka and Peeters, M. and Sclafani, F. and Smyth, E. and Valle, J. W. and Wagner, A. D. and Wyrwicz, L. and Fontana, E. and Moehler, M.}, article_location = {AMSTERDAM}, article_number = {2}, doi = {http://dx.doi.org/10.1016/j.esmoop.2022.100392}, keywords = {oesophagus cancer; stomach cancer; pancreatic cancer; neuroendocrine tumours; colorectal cancer}, language = {eng}, issn = {2059-7029}, journal = {ESMO OPEN}, title = {ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective}, url = {https://www.sciencedirect.com/science/article/pii/S2059702922000126?via%3Dihub}, volume = {7}, year = {2022} }
TY - JOUR ID - 2250084 AU - Koessler, T. - Alsina, M. - Arnold, D. - Ben-Aharon, I. - Collienne, M. - Lutz, M. P. - Neuzillet, C. - Obermannová, Radka - Peeters, M. - Sclafani, F. - Smyth, E. - Valle, J. W. - Wagner, A. D. - Wyrwicz, L. - Fontana, E. - Moehler, M. PY - 2022 TI - ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective JF - ESMO OPEN VL - 7 IS - 2 SP - 1-8 EP - 1-8 PB - ELSEVIER SN - 20597029 KW - oesophagus cancer KW - stomach cancer KW - pancreatic cancer KW - neuroendocrine tumours KW - colorectal cancer UR - https://www.sciencedirect.com/science/article/pii/S2059702922000126?via%3Dihub N2 - There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future. ER -
KOESSLER, T., M. ALSINA, D. ARNOLD, I. BEN-AHARON, M. COLLIENNE, M. P. LUTZ, C. NEUZILLET, Radka OBERMANNOVÁ, M. PEETERS, F. SCLAFANI, E. SMYTH, J. W. VALLE, A. D. WAGNER, L. WYRWICZ, E. FONTANA a M. MOEHLER. ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective. \textit{ESMO OPEN}. AMSTERDAM: ELSEVIER, 2022, roč.~7, č.~2, s.~1-8. ISSN~2059-7029. Dostupné z: https://dx.doi.org/10.1016/j.esmoop.2022.100392.
|